Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer

Ali Raza Khaki, Yong Shan, Richard E. Nelson, Sapna Kaul, John L. Gore, Petros Grivas, Stephen B. Williams

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations

    Fingerprint

    Dive into the research topics of 'Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences